Public annual accounts

PHARMACIE DU BON PASTEUR financials

Name: PHARMACIE DU BON PASTEUR financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for PHARMACIE DU BON PASTEUR, with comparable measures and links to available source documents.

Company overview

Registry number

0808953175

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 28, 2026

Financial evidence

Latest movements for PHARMACIE DU BON PASTEUR

2025 versus 2024

Operating line: €628,336
EBITDA: €443,379
Total assets: €3,665,259
Equity: €1,265,715

EBITDA margin +70.6% · Equity ratio +34.5%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€628,336	€443,379	€3,665,259	€1,265,715	-
202431 Dec 2024	€558,941	€426,349	€1,671,946	€1,242,863	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report

Fiscal year

Gross margin

EBITDA

Total assets

Equity

Filing

202531 Dec 2025

€628,336

€443,379

€3,665,259

€1,265,715

202431 Dec 2024

€558,941

€426,349

€1,671,946

€1,242,863